Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genteel is a private medical device company focused on diabetes care and blood glucose monitoring. Its core product line is the Genteel lancing device, a vacuum-assisted blood sampling system designed to enable gentler, alternate-site capillary blood collection for people with diabetes. The company markets its devices and Butterfly Touch lancets directly to consumers and highlights use cases across type 1 diabetes, type 2 diabetes, gestational diabetes, and CGM users. Genteel appears to be a commercial-stage healthcare company rather than a therapeutics developer, with its value proposition centered on reducing fingerstick pain, improving testing adherence, and supporting day-to-day diabetes management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genteel.